SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001808665-20-000013
Filing Date
2020-05-21
Accepted
2020-05-21 21:06:07
Documents
2
Period of Report
2020-05-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159010954936025.html 4  
1 FORM 4 wf-form4_159010954936025.xml 4 3506
2 2020WHEADONPOA a2020wheadonpoa.htm EX-24 4019
  Complete submission text file 0001808665-20-000013.txt   8954
Mailing Address C/O ASSERTIO THERAPEUTICS, INC. 100 SOUTH SAUNDERS ROAD, SUITE 300 LAKE FOREST IL 60045
Business Address
Wheadon David E. (Reporting) CIK: 0001789507 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39294 | Film No.: 20903460

Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Issuer) CIK: 0001808665 (see all company filings)

IRS No.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations